Medicare Enrolled
Dr. Amneet Virk Dulai, MD
Rheumatology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Virk Dulai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Virk Dulai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Virk Dulai
Dr. Amneet Virk Dulai is a rheumatology specialist in Fresno, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Virk Dulai performed 125,127 Medicare services across 2,746 unique beneficiaries.
Between the years covered by Open Payments, Dr. Virk Dulai received a total of $14,136 from 40 pharmaceutical and/or device companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Virk Dulai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in CA
$14,136 industry payments
Medicare Practice Summary
Medicare Utilization ↗125,127
Medicare services
Top 4% in CA for rheumatology
2,746
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,952 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 60,120 | $5 | $7 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
38,858 | $11 | $50 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
13,050 | $34 | $65 |
| Denosumab injection (Prolia/Xgeva) | 4,501 | $18 | $40 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,190 | $26 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
995 | $96 | $170 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
585 | $1 | $20 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
572 | $1 | $15 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
527 | $55 | $175 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
504 | $8 | $10 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
491 | $4 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
480 | $8 | $35 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
458 | $5 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
449 | $10 | $40 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
256 | $0 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
205 | $11 | $75 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
149 | $24 | $200 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
129 | $44 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
123 | $63 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
123 | $137 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $69 | $120 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
90 | $113 | $300 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
66 | $53 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $118 | $200 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
34 | $43 | $120 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $106 | $135 |
| New patient office visit, complex (60-74 min) | 12 | $161 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.2% high complexity
52.9% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,136
Total received (2018-2024)
Avg $2,019/year across 7 years
Top 22% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
856
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,099 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,480
2023
$1,864
2022
$2,173
2021
$2,238
2020
$1,843
2019
$2,303
2018
$2,236
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$221
Janssen Biotech, Inc.
$199
ABBVIE INC.
$178
GlaxoSmithKline, LLC.
$140
UCB, Inc.
$115
Fresenius Kabi USA, LLC
$98
AstraZeneca Pharmaceuticals LP
$96
PFIZER INC.
$91
Alexion Pharmaceuticals, Inc.
$85
Novartis Pharmaceuticals Corporation
$50
Aurinia Pharma U.S., Inc.
$46
Genentech USA, Inc.
$29
SOBI, INC
$29
Ultragenyx Pharmaceutical Inc.
$23
Organon Llc
$22
Biocon Biologics Inc
$20
Radius Health, Inc.
$19
ANI Pharmaceuticals, Inc.
$18
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,958
Janssen Biotech, Inc.
$2,188
UCB, Inc.
$1,132
PFIZER INC.
$922
GlaxoSmithKline, LLC.
$744
AbbVie Inc.
$672
Novartis Pharmaceuticals Corporation
$658
Horizon Therapeutics plc
$572
ABBVIE INC.
$406
Janssen Scientific Affairs, LLC
$374
Mallinckrodt Hospital Products Inc.
$372
Genentech USA, Inc.
$367
AstraZeneca Pharmaceuticals LP
$323
E.R. Squibb & Sons, L.L.C.
$312
Lilly USA, LLC
$301
Boehringer Ingelheim Pharmaceuticals, Inc.
$255
Aurinia Pharma U.S., Inc.
$217
AbbVie, Inc.
$156
Fresenius Kabi USA, LLC
$147
Mallinckrodt Enterprises LLC
$118
Alexion Pharmaceuticals, Inc.
$111
GENZYME CORPORATION
$91
Boston Scientific Corporation
$83
Ultragenyx Pharmaceutical Inc.
$76
ANI Pharmaceuticals, Inc.
$66
Horizon Pharma plc
$60
Mallinckrodt LLC
$54
Flexion Therapeutics, Inc.
$49
SANOFI-AVENTIS U.S. LLC
$47
MEDAC PHARMA, INC.
$45
Celgene Corporation
$42
Radius Health, Inc.
$41
SOBI, INC
$29
MEDEXUS PHARMA, INC.
$27
Bioventus LLC
$23
Organon Llc
$22
Exeltis, USA Inc.
$21
Biocon Biologics Inc
$20
Mylan Institutional Inc.
$18
Organon LLC
$17
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · GELSYN 3 · HUMIRA · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · Otezla · PENNSAID · PREVNAR 20 · PURIFIED CORTROPHIN GEL · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Spectra WaveWriter · Strensiq · TALTZ · TAVNEOS · TREMFYA · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
12
Per 100K population
1.2
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Virk Dulai is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Virk Dulai experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Virk Dulai performed 60,120 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Virk Dulai receive payments from pharmaceutical companies?
Yes. Dr. Virk Dulai received a total of $14,136 from 40 companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Virk Dulai's costs compare to other rheumatologists in Fresno?
Dr. Virk Dulai's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Virk Dulai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Fresno
Browse rheumatologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology